Recombinant DNA technology has been largely developed in microorganisms to produce substantial quantities of pharmacologically active compounds ().An example is the production of several flavonoid compounds with therapeutic activities by reconstituting the phenylpropanoid pathway in microbes such as Escherichia coli (21, 49) and Saccharomyces cerevisiae (22, 52).
